A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Clinical trial NCT01470313 · TERMINATED

Trial details

NCT number: NCT01470313
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Lupus Erythematosus

Start date: 2011-11-01
Primary completion: 2013-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.